RQCD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.002600E-01
Normal-vs-Stage2
9.607200E-01
Normal-vs-Stage3
1.520410E-01
Normal-vs-Stage4
3.673000E-01
Stage1-vs-Stage2
6.700800E-01
Stage1-vs-Stage3
2.681400E-01
Stage1-vs-Stage4
2.157600E-01
Stage2-vs-Stage3
1.265010E-01
Stage2-vs-Stage4
2.133800E-01
Stage3-vs-Stage4
5.456000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.625400E-01
Normal-vs-AfricanAmerican
7.683600E-01
Normal-vs-Asian
9.529200E-01
Caucasian-vs-AfricanAmerican
5.620600E-01
Caucasian-vs-Asian
8.151800E-01
AfricanAmerican-vs-Asian
7.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.707000E-01
Normal-vs-Female
9.726400E-01
Male-vs-Female
7.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.607200E-01
Normal-vs-Age(41-60Yrs)
6.179800E-01
Normal-vs-Age(61-80Yrs)
8.374800E-01
Normal-vs-Age(81-100Yrs)
4.535600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.303800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.520800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.473600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.102140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.308300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.615200E-01
Normal-vs-Daily Drinker
3.969200E-01
Normal-vs-Weekly Drinker
9.560600E-01
Normal-vs-Occasional Drinker
5.282400E-01
Normal-vs-Social Drinker
8.776400E-01
Non Drinker-vs-Daily Drinker
7.126200E-01
Non Drinker-vs-Weekly Drinker
2.580000E-01
Non Drinker-vs-Occasional Drinker
7.502500E-03
Non Drinker-vs-Social Drinker
1.084960E-01
Daily Drinker-vs-Weekly Drinker
1.960980E-01
Daily Drinker-vs-Occasional Drinker
8.483900E-03
Daily Drinker-vs-Social Drinker
8.462300E-02
Weekly Drinker-vs-Occasional Drinker
2.238000E-01
Weekly Drinker-vs-Social Drinker
7.338800E-01
Occasional Drinker-vs-Social Drinker
3.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.834800E-01
Normal-vs-Grade 2
1.085750E-01
Normal-vs-Grade 3
1.062990E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.528200E-02
Grade 1-vs-Grade 3
5.367900E-02
Grade 1-vs-Grade 4
3.834800E-01
Grade 2-vs-Grade 3
9.583600E-01
Grade 2-vs-Grade 4
1.085750E-01
Grade 3-vs-Grade 4
1.062990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.437800E-01
Normal-vs-NonDiabetic
9.024600E-01
Diabetic-vs-NonDiabetic
2.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.478000E-01
Normal-vs-NoPancreatitis
8.754400E-01
Pancreatitis-vs-NoPancreatitis
8.491600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.593200E-01
Normal-vs-N1
9.901400E-01
N0-vs-N1
8.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.924400E-01
Normal-vs-TP53-NonMutant
9.888600E-01
TP53-Mutant-vs-TP53-NonMutant
6.112100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
